Global /South Korea /Healthcare /Drug Manufacturers - General /002620
chevron_leftBack
Jeil Pharma Holdings Inc. logo

Jeil Pharma Holdings Inc.

002620
KRX: 002620 Delayed
9,000KRW -1.1%
5.93 USD
As of 14 June 2026, Jeil Pharma Holdings Inc. has a market cap of $91.86M USD, ranking #26143 globally and #1288 in South Korea. It ranks #2340 in the Healthcare sector, and #844 in the Drug Manufacturers - General industry.
Global Rank
26143
Country Rank
1288
Sector Rank
2340
Industry Rank
844
Key Stats
Market Cap
$91.86MUSD
139.7B KRW
Enterprise Value
$249.06MUSD
378.13B KRW
Revenue (TTM)
$432.41MUSD
657.61B KRW
EBITDA (TTM)
$35.52MUSD
53.94B KRW
Net Income (TTM)
$9.62MUSD
14.64B KRW
EBITDA Margin
8.2%
Profit Margin
2.2%
PE Ratio
9.5
PS Ratio
0.2
PB Ratio
0.3
EV/EBITDA
6.9
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Seung-Soo Han open_in_new
Employees
37
Founded
1959
Website
jeilpharm.co.kr open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-1.1% 1.1% 4.2% 14% 9% 15%

News

Loading...

Markets

Exchange Ticker Price
Korea Exchange
MIC: XKRX
PRIMARY
002620
제일파마홀딩스(주)
ISIN: KR7002620003
Shares Out.:
15.351M1 Shares Float: 2.083M2
TV:
SA:
YF:
GF:
BA:
MS:
9,000 KRW
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Jeil Pharma Holdings Inc.

Jeil Pharma Holdings Inc manufactures and sells ingredients of drugs, incrementally modified drugs, and generic drugs in South Korea. The company offers active pharmaceutical ingredients in the areas of antibiotics, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamines, as well as patch products. It also provides finished dosage forms in the areas of anti-bacteria and anti-fungal, anti-virus, cardiovascular, endocrinology, neurology, gastrointestinal, urology, oncology, anti-histamine, rheumatology, respiratory, otolaryngological, heaptic, laxatives, and purgatives. The company exports its products to approximately 40 countries in the Association of Southeast Asian Nations, Central and South America, Africa, etc. The company was founded in 1959 and is headquartered in Seoul, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)
Name
Market Cap diff.
PE
$9.15B
13.91T KRW
10K%
-
$6.77B
10.3T KRW
7K%
1958.1
$5.24B
7.97T KRW
6K%
29.9
298380
$4.96B
7.55T KRW
5K%
-
000100
$4.55B
6.92T KRW
5K%
35.9
$4.44B
6.76T KRW
5K%
-
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
829K%
38.1
JNJ
$547.28B
596K%
26.4
ABBV
$360.63B
393K%
97.4
$321.52B
256.25B CHF
350K%
19.9
AZN
$288.84B
215.59B GBP
314K%
27.6
NOVN
$274.65B
218.9B CHF
299K%
20.5
chevron_leftBack